It must be a bug going around because I never stated that Lympro is what brought Rubinfeld on board. I am well aware it is MANF. But that's not what Rubinfeld was referring to when he said what he said. Or was he talking about MANF? Based on what others reported, it wasn't about MANF but Lympro which is what my post was about in the first place. Try to stay on topic instead of misrepresenting what I wrote. But then again, you and a few others are clearly experts on misrepresenting what I write. Congrats!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
My Agenda: To see Amarantus prosper so I can make a nice return on my investment.